1. The effects of apelin treatment on a rat model of type 2 diabetes
    Raziye Akcılar et al, 2015, Advances in Medical Sciences CrossRef
  2. The Emerging Potential of the Apelin-APJ System in Heart Failure
    Jonathan R. Dalzell et al, 2015, Journal of Cardiac Failure CrossRef
  3. Impact of the 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene on primary nephrotic syndrome
    YUEZHONG LUO et al, 2014 CrossRef
  4. Adipokines, Vascular Wall, and Cardiovascular Disease
    Fabio Maresca et al, 2015, Angiology CrossRef
  5. Apelin/APJ expression in the heart and kidneys of hypertensive rats
    Rahime Sekerci et al, 2018, Acta Histochemica CrossRef
  6. Disease severity impacts the relationship of apelin with arterial function in patients with rheumatoid arthritis
    Sulé Gunter et al, 2018, Clin Rheumatol CrossRef
  7. Review: Apelin in disease
    Hanna Antushevich et al, 2018, Clinica Chimica Acta CrossRef
  8. Vascular effects of Apelin: Mechanisms and therapeutic potential
    Amreen Mughal et al, 2018, Pharmacology & Therapeutics CrossRef
  9. Resolvins as proresolving inflammatory mediators in cardiovascular disease
    Xavier Capó et al, 2018, European Journal of Medicinal Chemistry CrossRef
  10. Enhanced A1 adenosine receptor-induced vascular contractions in mesenteric artery and aorta of in L-NAME mouse model of hypertension
    Vishal R. Yadav et al, 2018, European Journal of Pharmacology CrossRef
  11. Apelin/APJ system: A novel promising target for neurodegenerative diseases
    Huaiqing Luo et al, 2019, J Cell Physiol CrossRef
  12. Apelin and its receptor APJ in cardiovascular diseases
    Xiao-Hua Yu et al, 2014, Clinica Chimica Acta CrossRef
  13. Apelin/APJ system: a promising therapy target for hypertension
    Di Wu et al, 2014, Mol Biol Rep CrossRef
  14. Protective Effects of Glucagon-like Peptide 1 on Endothelial Function in Hypertension
    Limei Liu et al, 2015, Journal of Cardiovascular Pharmacology CrossRef
  15. Effects of apelin on the cardiovascular system
    Anna Folino et al, 2015, Heart Fail Rev CrossRef
  16. The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review)
    Hawa N. Siti et al, 2015, Vascular Pharmacology CrossRef
  17. Renal protective effects of induction of haem oxygenase-1 combined with increased adiponectin on the glomerular vascular endothelial growth factor-nitric oxide axis in obese rats
    Xue Liu et al, 2015, Exp Physiol CrossRef
  18. Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells
    Mohamed I. Saad et al, 2015, Endocrine CrossRef
  19. MicroRNA-503 promotes angiotensin II-induced cardiac fibrosis by targeting Apelin-13
    Yuhong Zhou et al, 2016, J. Cell. Mol. Med. CrossRef
  20. Irisin improves perivascular adipose tissue dysfunction via regulation of the heme oxygenase-1/adiponectin axis in diet-induced obese mice
    Ningning Hou et al, 2016, Journal of Molecular and Cellular Cardiology CrossRef
  21. Cooperative action of APJ and α1A-adrenergic receptor in vascular smooth muscle cells induces vasoconstriction
    Katsumasa Nagano et al, 2019 CrossRef
  22. Cardiovascular response to small-molecule APJ activation
    Brandon Ason et al, 2020 CrossRef
  23. Long-Term Pharmacological Inhibition of the Activity of All NOS Isoforms Rather Than Genetic Knock-Out of Endothelial NOS Leads to Impaired Spatial Learning and Memory in C57BL/6 Mice
    Jhana O. Hendrickx et al, 2021, Biomedicines CrossRef
  24. Aortic Stiffness in L-NAME Treated C57Bl/6 Mice Displays a Shift From Early Endothelial Dysfunction to Late-Term Vascular Smooth Muscle Cell Dysfunction
    Sofie De Moudt et al, 2022, Front. Physiol. CrossRef
  25. Targeting the elabela/apelin-apelin receptor axis as a novel therapeutic approach for hypertension
    Jiawei Song et al, 2022 CrossRef
  26. L-carnitine: Searching for New Therapeutic Strategy for Sepsis Management
    Adeleh Sahebnasagh et al, 2022, CMC CrossRef
  27. Proteomic Assessment of C57BL/6 Hippocampi after Non-Selective Pharmacological Inhibition of Nitric Oxide Synthase Activity: Implications of Seizure-like Neuronal Hyperexcitability Followed by Tauopathy
    Jhana O. Hendrickx et al, 2022, Biomedicines CrossRef
  28. Chronic Inhibition of Nitric Oxide Synthases Impairs Spatiotemporal Learning and Memory to a Similar Extent in C57BL/6 and hAPP23+/− Mice
    Jhana O. Hendrickx et al, 2023, IJTM CrossRef
  29. A programmable protease-based protein secretion platform for therapeutic applications
    Xinyi Wang et al, 2024, Nat Chem Biol CrossRef
  30. Elevated level of urinary tellurium is a potential risk for increase of blood pressure in humans and mice
    Tomoko Misawa et al, 2024, Environment International CrossRef
  31. Apelin modulates inflammation and leukocyte recruitment in experimental autoimmune encephalomyelitis
    Hongryeol Park et al, 2024, Nat Commun CrossRef
  32. An update on novel and emerging therapeutic targets in Parkinson’s disease
    Richa Sawant et al, 2024, Metab Brain Dis CrossRef
  33. Unraveling the Complex Molecular Interplay and Vascular Adaptive Changes in Hypertension-Induced Kidney Disease
    Lyubomir Gaydarski et al, 2024, Biomedicines CrossRef